Showing 21 - 38 results of 38 for search '"Radiopharmaceutical"', query time: 0.04s Refine Results
  1. 21
  2. 22

    Investigating the significance of SPECT/CT-SUV for monitoring 177Lu-PSMA-targeted radionuclide therapy: a systematic review by Tahani O. Alkahtani

    Published 2025-01-01
    “…This imaging technique determines the radiopharmaceutical distribution and internal dosimetry in patients who receive TRT. …”
    Get full text
    Article
  3. 23

    Radiocobalt-Labeling of a Polypyridylamine Chelate Conjugated to GE11 for EGFR-Targeted Theranostics by Lorraine Gaenaelle Gé, Mathias Bogetoft Danielsen, Aaraby Yoheswaran Nielsen, Mathias Lander Skavenborg, Niels Langkjær, Helge Thisgaard, Christine J. McKenzie

    Published 2025-01-01
    “…In conclusion, [<sup>57</sup>Co]Co-TZTPEN-GE11 shows poor pharmacokinetics in a mouse model and is, therefore, not deemed suitable as a targeting radiopharmaceutical for EGFR.…”
    Get full text
    Article
  4. 24

    Detection Performance of 99mTc in Albira SI Small-Animal SPECT-CT by Jie TANG, Dong XU, Qianyue HU, Bo ZHANG, Wei LI, Lizhen WANG, Huixin YU, Fukuan ZHAO

    Published 2025-02-01
    “…Small-animal single-photon emission computed tomography-X-ray computed tomography (SPECT-CT) is an advanced imaging tool for preclinical research of single-photon radiopharmaceuticals. Its detection performance is the foundation of image quality and the reliability of experimental data. …”
    Get full text
    Article
  5. 25

    Comparison of ZnS(Ag) Scintillator and Proportional Counter Tube for Alpha Detection in Thin-Layer Chromatography by Marc Pretze, Jan Wendrich, Holger Hartmann, Robert Freudenberg, Ralph A. Bundschuh, Jörg Kotzerke, Enrico Michler

    Published 2024-12-01
    “…A difference was observed when measuring TLC with the AR-2000 in different modes; (4) <b>Conclusions</b>: The MiniScanPRO+ is fast, does not require additional equipment and can also measure the gamma spectrum, which may be important for some radiopharmaceutical production sites and regulatory authorities. …”
    Get full text
    Article
  6. 26

    PET imaging of 52Mn labeled DOTATATE and DOTAJR11 by James M. Omweri, Hailey A. Houson, Shannon E. Lynch, Volkan Tekin, Anna G. Sorace, Suzanne E. Lapi

    Published 2025-01-01
    “…Abstract Manganese-52 is gaining interest as an isotope for PET imaging due to its desirable decay and chemical properties for radiopharmaceutical development. Somatostatin receptor 2 (SSTR2) is significantly overexpressed by neuroendocrine tumors (NETs) and is an important target for nuclear imaging and therapy. …”
    Get full text
    Article
  7. 27
  8. 28
  9. 29
  10. 30
  11. 31
  12. 32
  13. 33

    Positron emission tomography molecular imaging for pathological visualization in multiple system atrophy by La Dong, Rui Zhou, Jinyun Zhou, Ke Liu, Chentao Jin, Jing Wang, Chenxi Xue, Mei Tian, Hong Zhang, Yan Zhong

    Published 2025-03-01
    “…In this review, we focused on the pathological mechanisms of MSA, summarized relevant targets and radiopharmaceuticals, and discussed the clinical applications and future perspectives of PET molecular imaging in MSA.…”
    Get full text
    Article
  14. 34
  15. 35

    Optimisation of low and ultra-low dose scanning protocols for ultra-extended field of view PET in a real-world clinical setting by Johanna Ingbritsen, Jason Callahan, Hugh Morgan, Melissa Munro, Robert E. Ware, Rodney J. Hicks

    Published 2025-01-01
    “…The Siemens Biograph Vision Quadra (Quadra), with an AFOV of 106cm, potentially allows use of significantly lower administered radiopharmaceuticals as well as reduced scan times. The aim of this study was to optimise acquisition protocols for routine clinical imaging with FDG on the Quadra the prioritisation of reduced activity given physical infrastructure constraints in our facility. …”
    Get full text
    Article
  16. 36

    On the reduction of imaging time-points for dosimetry in radionuclide therapy by Johan Gustafsson, Jan Taprogge

    Published 2025-02-01
    “…These formulae have the potential to be used for optimization of dosimetry measurement schemes for established and new radiopharmaceuticals as long as the mean and dispersion of biological half-lives are known in the patient population.…”
    Get full text
    Article
  17. 37

    Real-time trajectory imaging of alpha particles emitted from actinium-225 and its daughter radionuclides by Seiichi Yamamoto, Masao Yoshino, Kenji Shirasaki, Kohei Nakanishi, Kei Kamada, Akira Yoshikawa, Jun Kataoka

    Published 2025-01-01
    “…Abstract In targeted alpha-particle therapy, actinium-225 (Ac-225) has emerged as a radionuclide of potential, driving extensive efforts to develop innovative radiopharmaceuticals. High-resolution imaging of alpha particles is required for precisely detecting alpha-emitting radionuclides in cellular environments and small organs. …”
    Get full text
    Article
  18. 38